About David Wiant
Form D filings for Fuse Oncology in 2023 list David Wiant as executive officer.
David Wiant first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name David Wiant in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Wiant works with at each company, as listed on that company's latest Form D.
Fuse Oncology, Inc. · Form D, Apr 21, 2023
JM
John Miller
Director
JB
Jay Brennan
Director
BS
Benjamin Sintay
Executive officer
JS
John Strider
Executive officer
JB
James Bauler
Chief Executive Officer and director